VIVMF Insider Trading Activity and SEC Form 4 Filings
VIVMF insider trading summary
No open-market insider purchases or sales of Viveve Medical, Inc. (VIVMF) have been reported on SEC Form 4 in the past 12 months.
Latest VIVMF insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 17, 2016 | Daniel Janney | Director | Buy | $1.0M (200,000 @ $5.00) |
| Feb 25, 2016 | Patricia Scheller | Chief Executive Officer | Buy | $500 (588 @ $0.85) |
| Jan 25, 2016 | Patricia Scheller | Chief Executive Officer | Buy | $1000 (1,428 @ $0.70) |
| Dec 23, 2015 | Patricia Scheller | Chief Executive Officer | Buy | $999 (1,359 @ $0.74) |
| Nov 24, 2015 | Alta Bioequities Management, LLC | 10% Owner | Buy | $600K (857,142 @ $0.70) |
| Nov 24, 2015 | Alta Bioequities, L.P. | 10% Owner | Buy | $600K (857,142 @ $0.70) |
| Nov 24, 2015 | Stonepine Capital, L.P. | 10% Owner | Buy | $2.0M (2,857,142 @ $0.70) |
| Nov 24, 2015 | James G. Atkinson | CBO & President | Buy | $76K (109,105 @ $0.70) |
| Nov 24, 2015 | Patricia Scheller | Chief Executive Officer | Buy | $10K (14,285 @ $0.70) |
| Nov 24, 2015 | James G. Atkinson | CBO & President | Buy | $450K (642,857 @ $0.70) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.